Laura Scagnellato, Antonio Collesei, Andrea Doria, Giacomo Cozzi, Mariagrazia Lorenzin, Fabiola Atzeni, Serena Bugatti, Roberto Caporali, Alberto Cauli, Fabrizio Conti, Addolorata Corrado, Antonio Carletto, Maria Sole Chimenti, Rosario Foti, Bruno Frediani, Roberto Gerli, Roberto Gorla, Marcello Govoni, Elisa Gremese, Serena Guiducci, Annamaria Iagnocco, Florenzo Iannone, Simone Parisi, Maurizio Rossini, Fausto Salaffi, Leonardo Santo, Piercarlo Sarzi Puttini, Marco Sebastiani, Angelo Semerano, Gianfranco Ferraccioli, Giovanni Lapadula, Roberta Ramonda
OBJECTIVES: We aimed to investigate the effectiveness of tumour necrosis factor inhibitors (TNFi), anti-interleukin-17 or interleukin-12/23 monoclonal antibodies (anti-IL) on comorbidities in a cohort of patients with spondyloarthritis (SpA), using an average treatment effect (ATE) analysis. METHODS: SpA patients from the multicentre Italian GISEA Registry were divided into groups according to pharmacological exposure: no treatment (G0), TNFi (G1) and non-responders to TNFi switched to anti-IL (G2)...
August 30, 2023: Clinical and Experimental Rheumatology